Cubist Systematic Strategies’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-84,207
| Closed | -$3.31M | – | 4217 |
|
|
2023
Q2 | $3.31M | Buy |
84,207
+43,304
| +106% | +$1.53M | 0.02% | 1101 |
|
|
2023
Q1 | $995K | Sell |
40,903
-9,495
| -19% | -$208K | 0.01% | 2193 |
|
|
2022
Q4 | $1.08M | Sell |
50,398
-81,747
| -62% | -$1.74M | 0.01% | 2373 |
|
|
2022
Q3 | $2.37M | Sell |
132,145
-84,690
| -39% | -$1.11M | 0.01% | 1832 |
|
|
2022
Q2 | $2.09M | Buy |
+216,835
| New | +$2.72M | 0.01% | 1824 |
|
|
2022
Q1 | – | Sell |
-24,701
| Closed | -$413K | – | 3906 |
|
|
2021
Q4 | $413K | Sell |
24,701
-135,769
| -85% | -$2.23M | ﹤0.01% | 2588 |
|
|
2021
Q3 | $2.61M | Buy |
160,470
+142,273
| +782% | +$1.55M | 0.03% | 839 |
|
|
2021
Q2 | $115K | Buy |
+18,197
| New | +$117K | ﹤0.01% | 2701 |
|
|
2020
Q2 | – | Sell |
-17,339
| Closed | -$60K | – | 2572 |
|
|
2020
Q1 | $60K | Buy |
+17,339
| New | +$101K | ﹤0.01% | 1985 |
|
|
2018
Q3 | – | Sell |
-23,500
| Closed | -$64K | – | 2146 |
|
|
2018
Q2 | $64K | Buy |
+23,500
| New | +$64.8K | ﹤0.01% | 1616 |
|
|
2017
Q1 | – | Sell |
-8,328
| Closed | -$40K | – | 1921 |
|
|
2016
Q4 | $40K | Sell |
8,328
-6,666
| -44% | -$198K | ﹤0.01% | 1600 |
|
|
2016
Q3 | $692K | Buy |
+14,994
| New | +$846K | 0.04% | 569 |
|
|
2016
Q2 | – | Sell |
-9,022
| Closed | -$381K | – | 1932 |
|
|
2016
Q1 | $381K | Buy |
+9,022
| New | +$460K | 0.02% | 876 |
|
|
2015
Q4 | – | Sell |
-5,452
| Closed | -$221K | – | 2006 |
|
|
2015
Q3 | $221K | Buy |
+5,452
| New | +$289K | 0.01% | 1413 |
|
|
2015
Q2 | – | Sell |
-7,862
| Closed | -$366K | – | 2100 |
|
|
2015
Q1 | $366K | Sell |
7,862
-2,633
| -25% | -$137K | 0.02% | 1138 |
|
|
2014
Q4 | $471K | Buy |
+10,495
| New | +$441K | 0.03% | 895 |
|
Cubist Systematic Strategies's ISEE Position: Q3 2023 in Review
Cubist Systematic Strategies sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 84,207 shares — an estimated $3.31M sold.
Cubist Systematic Strategies first reported a position in ISEE in Q4 2014 and held it in 16 quarters. The position peaked at $3.31M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.
- Cubist Systematic Strategies reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- Cubist Systematic Strategies sold 84,207 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $3.31M.
- Cubist Systematic Strategies first reported a position in IVERIC bio, Inc. Common Stock in Q4 2014 and held it in 16 quarters.
- Cubist Systematic Strategies's IVERIC bio, Inc. Common Stock position peaked at $3.31M in Q2 2023.
- 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.
Based on Cubist Systematic Strategies's 13F filing for Q3 2023, filed 14 Nov 2023.